Dept. of the Army -- USAMRAA logo

DoW Ovarian Cancer, Clinical Trial Award

Dept. of the Army -- USAMRAA

Funding Amount

$5,600,000 total

Deadline

October 1, 2026

119 days left

Grant Type

federal

Overview

DoW Ovarian Cancer, Clinical Trial Award

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

Details

  • Agency: Dept. of the Army -- USAMRAA
  • Department: Department of Defense
  • Opportunity #: HT942526OCRPCTA
  • Total Funding: $5,600,000
  • Expected Awards: 2
  • Instrument: grant

Eligibility

Eligible Applicant Types

unrestricted

Focus Areas & Funding Uses

Fields of Work

science-research

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for DoW Ovarian Cancer, Clinical Trial Award?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found DoW Ovarian Cancer, Clinical Trial Award. Now let's win it.

Start writing